ES2426034T3 - Truncamientos y proteínas recombinantes de Porphyromonas gingivalis - Google Patents

Truncamientos y proteínas recombinantes de Porphyromonas gingivalis Download PDF

Info

Publication number
ES2426034T3
ES2426034T3 ES01925217T ES01925217T ES2426034T3 ES 2426034 T3 ES2426034 T3 ES 2426034T3 ES 01925217 T ES01925217 T ES 01925217T ES 01925217 T ES01925217 T ES 01925217T ES 2426034 T3 ES2426034 T3 ES 2426034T3
Authority
ES
Spain
Prior art keywords
gingivalis
polypeptide
seq
residues
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01925217T
Other languages
English (en)
Spanish (es)
Inventor
Ian George Barr
Larissa Czajkowski
Bruce Carter Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
University of Melbourne
Original Assignee
CSL Ltd
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd, University of Melbourne filed Critical CSL Ltd
Application granted granted Critical
Publication of ES2426034T3 publication Critical patent/ES2426034T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES01925217T 2000-04-28 2001-04-27 Truncamientos y proteínas recombinantes de Porphyromonas gingivalis Expired - Lifetime ES2426034T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ718200 2000-04-28
AUPQ7182A AUPQ718200A0 (en) 2000-04-28 2000-04-28 Porphyromonas gingivalis recombinant proteins and truncations
PCT/AU2001/000482 WO2001083530A1 (fr) 2000-04-28 2001-04-27 Troncatures et proteines recombinees de porphyromonas gingivalis

Publications (1)

Publication Number Publication Date
ES2426034T3 true ES2426034T3 (es) 2013-10-18

Family

ID=3821267

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01925217T Expired - Lifetime ES2426034T3 (es) 2000-04-28 2001-04-27 Truncamientos y proteínas recombinantes de Porphyromonas gingivalis

Country Status (9)

Country Link
US (1) US7204991B2 (fr)
EP (1) EP1276762B1 (fr)
JP (1) JP5209166B2 (fr)
AU (1) AUPQ718200A0 (fr)
CA (2) CA2750984A1 (fr)
DK (1) DK1276762T3 (fr)
ES (1) ES2426034T3 (fr)
NZ (1) NZ521797A (fr)
WO (1) WO2001083530A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US7378101B2 (en) 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
US7468185B2 (en) 2001-12-21 2008-12-23 Pfizer Inc. Vaccine for periodontal disease
AU2003294350A1 (en) * 2002-11-18 2004-06-15 Boston Medical Center Corporation Immunization with porphyromonas gingivalis protects against heart disease
WO2006084129A2 (fr) * 2005-02-01 2006-08-10 University Of Florida Research Foundation Genes du porphyromonas gingivalis w83 impliques dans l'invasion des cellules humaines
CA2652957A1 (fr) 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Polypeptides de porphyromonas gingivalis utiles dans la prevention de la parodontolyse
US20100297179A1 (en) 2007-07-12 2010-11-25 Stuart Geoffrey Dashper Immunology Treatment for Biofilms
AU2013203250B2 (en) * 2007-07-12 2014-11-13 Oral Health Australia Pty Ltd Immunology treatment for biofilms
WO2009006699A1 (fr) * 2007-07-12 2009-01-15 Oral Health Australia Pty Ltd Traitement de biofilm
DK2328914T3 (en) 2008-08-29 2017-07-10 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of P. gingivalis infection
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
EP4021437A1 (fr) * 2020-03-30 2022-07-06 Colgate-Palmolive Company Amélioration, maintien, protection et réparation de l'intégrité tissulaire, de la fonction barrière et de l'immunité au moyen d'une composition comprenant une source d'ions zinc

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536497A (en) * 1992-12-21 1996-07-16 The Research Foundation Of State University Of New York Fimbrial polypeptides useful in the prevention of periodontitis
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
US5475097A (en) * 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
ES2377751T3 (es) * 1997-12-10 2012-03-30 Csl Limited Polipéptidos y polinucleótidos de Porfiromonas gingivalis
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US20030083287A1 (en) * 2000-11-30 2003-05-01 Burgess Nicola A. ginS

Also Published As

Publication number Publication date
CA2750984A1 (fr) 2001-11-08
CA2407603C (fr) 2013-06-11
US20030215402A1 (en) 2003-11-20
EP1276762A1 (fr) 2003-01-22
NZ521797A (en) 2005-07-29
EP1276762B1 (fr) 2013-05-29
DK1276762T3 (da) 2013-08-19
JP2003531634A (ja) 2003-10-28
EP1276762A4 (fr) 2004-07-07
WO2001083530A1 (fr) 2001-11-08
US7204991B2 (en) 2007-04-17
AUPQ718200A0 (en) 2000-05-25
JP5209166B2 (ja) 2013-06-12
CA2407603A1 (fr) 2001-11-08

Similar Documents

Publication Publication Date Title
ES2388895T3 (es) Composición antigénica de P. gingivalis
RU2535898C2 (ru) Профилактика, лечение и диагностика инфекции, вызванной бактериями p.gingivalis
ES2255082T3 (es) Diagnostico y tratamiento de la enfermedad periodontal.
ES2426034T3 (es) Truncamientos y proteínas recombinantes de Porphyromonas gingivalis
AU771544B2 (en) Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
JP4358909B2 (ja) 歯周炎の診断および治療用のポルフィロモナス・ジンジバリス抗原
KR20010020417A (ko) 포피로모나스 긴기발리스 관련 치주염의 진단 및 치료용 합성 펩타이드 구조체
US5536497A (en) Fimbrial polypeptides useful in the prevention of periodontitis
AU2001252042B2 (en) Porphyromonas gingivalis recombinant proteins and truncations
AU775228B2 (en) P. gingivalis antigenic composition
Class et al. Patent application title: SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTIS ASSOCIATED WITH PORPHYROMONAS GINGIVALIS Inventors: Eric Charles Reynolds (Deepdene, AU) Neil Martin O'Brien-Simpson (Brunswick, AU) Nada Slakeski (Kew East, AU) Assignees: THE UNIVERSITY OF MELBOURNE
HK1149938B (en) P.gingivalis antigenic composition
AU2013203249A1 (en) Prevention, treatment and diagnosis of P.gingivalis infection